close
Share with your friends
This page uses JavaScript for some features – please enable JavaScript on your browser for the full experience.

Changing the lives
of people with HIV

How do you improve the quality of care for the 37 million people around the world living with HIV*?

That’s the important challenge that we are working with ViiV Healthcare to solve.

A joint venture between GSK, Pfizer and Shionogi, ViiV Healthcare is a leading pharmaceutical company specialising in HIV treatment. ViiV Healthcare is committed to ensuring that people living with HIV are optimally diagnosed, fully engaged in care and able to achieve successful treatment outcomes. This reflects ViiV Healthcare’s commitment to UNAID’s 90-90-90 initiative, which sets HIV treatment targets by 2020 of 90% of people living with HIV diagnosis; 90% of diagnosed people on antiretroviral treatment and 90% of people on treatment with a fully suppressed viral load.

Drawing on our strategic, clinical and scientific expertise and networks in the healthcare sector, we worked with ViiV Healthcare to co-design Positive Pathways – an ongoing, transformational programme to share current examples of best practices in HIV care within and across countries. The aims of the programme are to contribute towards the global eradication of HIV, reduce morbidity and mortality rates and increase overall quality of life.

For Positive Pathways, we conducted primary research with some of the most renowned HIV centres globally. We also assembled an advisory board of medical, scientific, patient and policy experts to review and prioritise findings. After identifying a shortlist of 21 priority interventions to improve the quality of care patients receive, we suggested a number of immediate actions to make a demonstrable short-term difference to people living with HIV. This included providing a bus service from rural areas to specialist clinics, and partnering patients in a buddy system to ensure patients attend appointments and remain in care.

The initial phase of the programme was focussed largely on Europe and the US, but was so well received that it has now expanded internationally to include Australia, Japan, Taiwan, Brazil, Jamaica and South Korea.

Michele Robbins, Senior Director, Global Strategic Initiatives at ViiV Healthcare, said: “This programme delivered our objectives and more. One of our steering committee physicians said that this was one of the best programmes he has been a part of in his 25 years of working in HIV.”

Adrienne Rivlin, KPMG Partner in the UK and project lead, said: “I’m extremely proud of our work with ViiV Healthcare to provide solutions to address this important challenge. Through our work identifying and analysing evidence-based approaches to care and sharing them worldwide we’re helping people living with HIV to lead better quality lives.”

This programme delivered our objectives and more. One of our steering committee physicians said that this was one of the best programmes he has been a part of in his 25 years of working in HIV.

Michele Robbins, Senior Director, Global Strategic Initiatives at ViiV Healthcare

*Data sourced online from the World Health Organisation: http://www.who.int/gho/hiv/en/.